首页 | 本学科首页   官方微博 | 高级检索  
     


Anti-myeloma potential of ruxolitinib in co-existing JAK2V617F-positive smouldering myeloma and polycythaemia vera
Authors:Holly Lee  Sylvia McCulloch  Etienne Mahe  Mona Shafey  Fariborz Rashid-Kolvear  Faisal Khan  Dwip Prajapati  Paola Neri  Peter Duggan  Jason Tay  Nizar Bahlis  Victor H Jimenez-Zepeda
Affiliation:1. Department of Hematology, University of Calgary, Calgary, Alberta, Canada;2. Tom Baker Cancer Center, Department of Medical Oncology and Hematology, University of Calgary, Calgary, Alberta, Canada;3. Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada;4. Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada

Department of Medical Genetics, University of Calgary, Calgary, Alberta, Canada;5. Department of Pediatric Hematology, University of Calgary, Calgary, Alberta, Canada;6. Department of Medical Oncology, University of Calgary, Calgary, Alberta, Canada

Abstract:
Keywords:malignant haematology  molecular analysis  myeloma  myeloproliferative disease  polycythaemia vera
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号